Retatrutide — 20mg

Description

Retatrutide (LY3437943) research product

Retatrutide is an investigational peptide studied as a combined agonist of the GLP-1, GIP, and glucagon receptors. It is used in controlled laboratory models examining multi-receptor signaling and metabolic pathway interactions.

Product specifications

• Compound: Retatrutide (LY3437943)
• Labeled amount: 20mg
• Format: Single research vial
• Intended use: Laboratory research only

Research focus

Common areas of controlled laboratory investigation include:

• GLP-1, GIP, and glucagon receptor signaling
• Multi-receptor pathway interactions
• Incretin and metabolic signaling models

Catalog details and comparison

This listing represents single research vial labeled at 20mg. Match the product title, label, amount, format, price, and current stock state before ordering. Inventory is enforced at checkout and backorders are disabled.

Use compound-specific literature and an appropriate analytical method for the research question being studied. Compare this material within the GLP and Weight Loss, or review the research peptide supplier evaluation guide for a broader catalog checklist.

Retatrutide research guide: Review the triple-receptor profile, molecular design, evidence layers, and analytical identity considerations.

Testing documentation

Testing documentation is available. Certificates of analysis will be posted to the site as they become available.

Before checkout, review ELMNTPEP shipping information and payment options. Availability shown on this page reflects the current orderable stock state.

Research use notice

For laboratory research use only. Not for human or veterinary use. This listing does not provide medical, dosing, administration, or therapeutic guidance.